The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haneji, N.
Right arrow Articles by Hayashi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haneji, N.
Right arrow Articles by Hayashi, Y.

The Journal of Immunology, Vol 153, Issue 6 2769-2777, Copyright © 1994 by American Association of Immunologists


ARTICLES

A new animal model for primary Sjogren's syndrome in NFS/sld mutant mice

N Haneji, H Hamano, K Yanagi and Y Hayashi
Department of Pathology, Tokushima University School of Dentistry, Japan.

In this study, we report an established and characterized animal model for primary Sjogren's syndrome in NFS/sld mutant mice bearing an autosomal recessive gene with sublingual gland differentiation arrest. Significant inflammatory changes develop spontaneously in both the salivary and lacrimal glands of NFS/sld mutant mice thymectomized 3 days after birth without any immunization, whereas no significant inflammatory lesions were found in other organs or in nonthymectomized mice. This pathology resembles primary Sjogren's syndrome in humans, which involves the parotid, submandibular salivary, and lacrimal glands. A significantly higher incidence of autoimmune lesions was found in female mice, and the anti-salivary duct autoantibodies were detected in sera from mice with autoimmune lesions but not in control mice. The inflammatory infiltration into the salivary and lacrimal glands consisted mainly of CD3+ and CD4+ T cells, and a lesser proportion of CD8+ T cells and B220+ B cells during the course of disease. When the repertoire of TCR V beta genes transcribed and expressed within the inflammatory infiltrates was analyzed in mice with autoimmune lesions, a considerable preferential use of TCR V beta gene (V beta 8 predominant) was detected in these lesions from the onset of disease. Thus, we can propose a newly established animal model for primary Sjogren's syndrome developing in this mutant strain of mice. Moreover, the predominant patterns of TCR transcript expression in an animal model may be somewhat restricted, suggesting that TCR-based immunotherapy of Sjogren's syndrome is possible.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Oak, J. A. Deane, M. G. Kharas, J. Luo, T. E. Lane, L. C. Cantley, and D. A. Fruman
Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase
PNAS, November 7, 2006; 103(45): 16882 - 16887.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. H. Scofield, S. Asfa, D. Obeso, R. Jonsson, and B. T. Kurien
Immunization with Short Peptides from the 60-kDa Ro Antigen Recapitulates the Serological and Pathological Findings as well as the Salivary Gland Dysfunction of Sjogren's Syndrome
J. Immunol., December 15, 2005; 175(12): 8409 - 8414.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kuroda, T. Mitani, N. Takeda, N. Ishimaru, R. Arakaki, Y. Hayashi, Y. Bando, K. Izumi, T. Takahashi, T. Nomura, et al.
Development of Autoimmunity against Transcriptionally Unrepressed Target Antigen in the Thymus of Aire-Deficient Mice
J. Immunol., February 15, 2005; 174(4): 1862 - 1870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Takada, M. Takiguchi, A. Konno, and M. Inaba
Autoimmunity against a Tissue Kallikrein in IQI/Jic Mice: A MODEL FOR SJOGREN'S SYNDROME
J. Biol. Chem., February 4, 2005; 280(5): 3982 - 3988.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Takada, M. Takiguchi, A. Konno, and M. Inaba
Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome
Rheumatology, July 1, 2004; 43(7): 858 - 862.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M R Kok, B J Baum, P P Tak, and S R Pillemer
Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome
Ann Rheum Dis, November 1, 2003; 62(11): 1038 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Roper, R. D. McAllister, J. E. Biggins, S. D. Michael, S. H. Min, K. S. K. Tung, S. B. Call, J. Gao, and C. Teuscher
Aod1 Controlling Day 3 Thymectomy-Induced Autoimmune Ovarian Dysgenesis in Mice Encompasses Two Linked Quantitative Trait Loci with Opposing Allelic Effects on Disease Susceptibility
J. Immunol., June 15, 2003; 170(12): 5886 - 5891.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Saegusa, N. Ishimaru, K. Yanagi, K. Mishima, R. Arakaki, T. Suda, I. Saito, and Y. Hayashi
Prevention and Induction of Autoimmune Exocrinopathy Is Dependent on Pathogenic Autoantigen Cleavage in Murine Sjogren's Syndrome
J. Immunol., July 15, 2002; 169(2): 1050 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Crit. Rev. Oral Biol. Med.Home page
S. Cha, A.B. Peck, and M.G. Humphreys-Beher
PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE
Crit. Rev. Oral. Biol. Med., January 1, 2002; 13(1): 5 - 16.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Ishimaru, K. Yanagi, K. Ogawa, T. Suda, I. Saito, and Y. Hayashi
Possible Role of Organ-Specific Autoantigen for Fas Ligand-Mediated Activation-Induced Cell Death in Murine Sjogren's Syndrome
J. Immunol., November 15, 2001; 167(10): 6031 - 6037.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Zoukhri and C. L. Kublin
Impaired Neurotransmitter Release from Lacrimal and Salivary Gland Nerves of a Murine Model of Sjogren's Syndrome
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 925 - 932.
[Abstract] [Full Text]


Home page
IOVSHome page
K. Tsubota, H. Fujita, K. Tadano, T. Takeuchi, T. Murakami, I. Saito, and Y. Hayashi
Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome
Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 101 - 110.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Saegusa, N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi
Autoantigen-Specific CD4+CD28low T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjogren's Syndrome
J. Immunol., August 15, 2000; 165(4): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S.-i. Hirai, N. Ishida, K. Watanabe, and S. Mita
Leakage of Aquaporin 5 in the Tear of Dacryoadenitis Mice
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2432 - 2437.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
N. Ishimaru, T. Yoneda, K. Saegusa, K. Yanagi, N. Haneji, K. Moriyama, I. Saito, and Y. Hayashi
Severe Destructive Autoimmune Lesions with Aging in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis
Am. J. Pathol., May 1, 2000; 156(5): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Ishimaru, K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi
Estrogen Deficiency Accelerates Autoimmune Exocrinopathy in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis
Am. J. Pathol., July 1, 1999; 155(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Saito, K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, et al.
Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10
J. Immunol., March 1, 1999; 162(5): 2488 - 2494.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
N. Haneji, T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi
Identification of alpha -Fodrin as a Candidate Autoantigen in Primary Sjögren's Syndrome
Science, April 25, 1997; 276(5312): 604 - 607.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.